Compare IDEXX Laboratories, Inc. (IDXX) vs Vipshop Holdings Ltd - ADR (VIPS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Vipshop Holdings Ltd - ADR — how do they compare? IDEXX Laboratories, Inc. trades at $571 (market cap $46.22B), while Vipshop Holdings Ltd - ADR trades at $15.06 (market cap $7.20B). The key difference: IDEXX Laboratories, Inc. is far larger — about 6.4× Vipshop Holdings Ltd - ADR's market cap, and Vipshop Holdings Ltd - ADR pays a 4.14% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals.
| IDXX | VIPS | |
|---|---|---|
Market Cap | $46.22B | $7.20B |
Sector | Health | Consumer Cyclical |
52-Week High | $766.68 | $20.68 |
52-Week Low | $526.44 | $12.92 |
Enterprise Value | $47.12B | $3.76B |
Dividend Yield | — | 4.14% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $570.58, down 4.23% over 24 hours, with a bullish technical signal and strong fundamentals. The stock has consistently beaten earnings estimates, with Q2 2026 EPS of $4.27 surpassing the $3.94 expectation. Revenue growth remains robust, supported by a 74.21% ROE and expanding diagnostic offerings. Recent news highlights product expansion, including a dual-species cardiac test, reinforcing its market leadership in veterinary diagnostics.
The outlook is positive, driven by durable competitive advantages and international growth potential. However, elevated valuation multiples and competitive pressures pose risks. Analyst consensus is bullish with a $683.33 price target, suggesting significant upside from current levels, though investors should monitor execution on guidance and macroeconomic headwinds.
Vipshop (VIPS) trades at $14.49, down 5.97% over 24 hours, with a bullish technical signal from moving averages but mixed oscillators. The stock shows attractive valuation metrics, including a P/E of 6.79 and P/S of 0.48, alongside strong profitability with an 18.43% ROE. Recent earnings have been mixed, with Q1 2026 EPS meeting expectations, while the company pursues growth through an outlet strategy and REIT spin-off.
The outlook remains positive due to low valuations and profitability, but risks include revenue stagnation and competitive pressures. Analyst consensus is bullish with 53.57% buy ratings, supporting potential upside if earnings growth resumes in 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Vipshop Holdings Ltd - ADR
Vipshop Holdings Ltd is an online discount retailer for brands in China. The company offers branded products to consumers in China through flash sales on its vipshop.com, vip.com and lefeng.com websites. Flash sales represent an online retail format combining the advantages of e-commerce and discount sales through selling a finite quantity of discounted products or services online for a limited period of time. It deals in a wide range of products and services for consumers specializing in branded cosmetics, apparel, healthcare products, food and other consumer products. Its operating segment includes Vip.com and Shan Shan Outlets. The company generates maximum revenue from Vip.com segment.
Read more on VIPS →
